Table 3.
Plasma magnesium quintiles in relation to total ischemic stroke, thrombotic and embolic strokes (RR [95% CI])
| Plasma Magnesium, mmol/l
| ||||||
|---|---|---|---|---|---|---|
| Quintile 1 | Quintile 2 | Quintile 3 | Quintile 4 | Quintile 5 | p-trend | |
| Range | 0.7 – < 0.82 | 0.82 – < 0.86 | 0.86 – < 0.90 | 0.90 – < 0.95 | 0.95 – 1.15 | |
| Total Ischemic Stroke | ||||||
| Cases/Controls | 106/71 | 77/86 | 96/113 | 76/96 | 104/93 | |
| Model 1 | 1.34 (0.86–2.10) | 0.85 (0.55–1.32) | 0.75 (0.49–1.15) | 0.73 (0.48–1.10) | 1.00 | 0.13 |
| Model 2 | 1.24 (0.78–1.98) | 0.81 (0.51–1.28) | 0.75 (0.48–1.15) | 0.72 (0.47–1.10) | 1.00 | 0.29 |
| Model 3 | 1.34 (0.82–2.17) | 0.86 (0.53–1.38) | 0.83 (0.53–1.31) | 0.75 (0.48–1.16) | 1.00 | 0.19 |
| Thrombotic Stroke | ||||||
| Cases/Controls | 62/44 | 60/56 | 60/72 | 57/67 | 64/64 | |
| Model 1 | 1.46 (0.84–2.53) | 0.11 (0.65–1.90) | 0.84 (0.50–1.43) | 0.88 (0.54–1.42) | 1.00 | 0.11 |
| Model 2 | 1.46 (0.83–2.58) | 1.03 (0.59–1.81) | 0.82 (0.47–1.43) | 0.83 (0.50–1.37) | 1.00 | 0.15 |
| Model 3 | 1.63 (0.89–2.98) | 1.09 (0.61–1.95) | 0.94 (0.53–1.68) | 0.86 (0.51–1.45) | 1.00 | 0.09 |
| Embolic Stroke | ||||||
| Cases/Controls | 37/24 | 15/24 | 29/36 | 17/23 | 31/22 | |
| Model 1 | 1.09 (0.46–2.60) | 0.50 (0.21–1.21) | 0.58 (0.27–1.24) | 0.55 (0.24–1.29) | 1.00 | 0.80 |
| Model 2 | 0.90 (0.34–2.38) | 0.47 (0.18–1.25) | 0.64 (0.26–1.56) | 0.42 (0.16–1.11) | 1.00 | 0.94 |
| Model 3 | 1.12 (0.39–3.19) | 0.54 (0.20–1.48) | 0.74 (0.29–1.90) | 0.44 (0.16–1.20) | 1.00 | 0.72 |
Quintiles of magnesium based on distribution in controls
Model 1: Matching factors only (on age, race/ethnicity, smoking, date of blood draw, fasting status, menopausal status and hormone use)
Model 2: Model 1 + alcohol, BMI, physical activity, aspirin, thiazide diuretics
Model 3: Model 2 + HbA1c, History of diabetes, hypertension, CHD and total/HDL cholesterol